Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging

One of the most clinically relevant molecular aberrations in breast cancer is overexpression of human epidermal growth factor receptor type 2 (HER2). We aimed to develop a radiolabeled tyrosine kinase inhibitor for HER2-targeted breast cancer imaging. In this study, a radioiodinated analog ((125/131...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Tang, Longguang, Peng, Chenyu, Tang, Bowen, Li, Zijing, Wang, Xiangyu, Li, Jindian, Gao, Fei, Huang, Lumei, Xu, Duo, Zhang, Pu, Zhuang, Rongqiang, Su, Xinhui, Chen, Xiaoyuan, Zhang, Xianzhong
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6126446/
https://ncbi.nlm.nih.gov/pubmed/29653973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.205088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados